It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INGN’s FA Score shows that 0 FA rating(s) are green whileZTEK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INGN’s TA Score shows that 5 TA indicator(s) are bullish while ZTEK’s TA Score has 4 bullish TA indicator(s).
INGN (@Medical/Nursing Services) experienced а +5.71% price change this week, while ZTEK (@Pharmaceuticals: Other) price change was -4.30% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.89%. For the same industry, the average monthly price growth was +5.50%, and the average quarterly price growth was +9.92%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.
INGN is expected to report earnings on Nov 05, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+3.91% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
INGN | ZTEK | INGN / ZTEK | |
Capitalization | 215M | 68.9M | 312% |
EBITDA | -12.16M | -8.14M | 149% |
Gain YTD | -13.195 | -28.723 | 46% |
P/E Ratio | N/A | N/A | - |
Revenue | 343M | 925K | 37,081% |
Total Cash | 122M | 2.89M | 4,223% |
Total Debt | 19M | 1.88M | 1,013% |
INGN | ZTEK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 95 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 50 | 93 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ZTEK's Valuation (60) in the null industry is in the same range as INGN (82) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to INGN’s over the last 12 months.
ZTEK's Profit vs Risk Rating (95) in the null industry is in the same range as INGN (100) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to INGN’s over the last 12 months.
ZTEK's SMR Rating (100) in the null industry is in the same range as INGN (100) in the Medical Specialties industry. This means that ZTEK’s stock grew similarly to INGN’s over the last 12 months.
INGN's Price Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for ZTEK (93) in the null industry. This means that INGN’s stock grew somewhat faster than ZTEK’s over the last 12 months.
INGN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as ZTEK (100) in the null industry. This means that INGN’s stock grew similarly to ZTEK’s over the last 12 months.
INGN | ZTEK | |
---|---|---|
RSI ODDS (%) | N/A | 1 day ago90% |
Stochastic ODDS (%) | 1 day ago88% | 1 day ago79% |
Momentum ODDS (%) | 1 day ago78% | 1 day ago88% |
MACD ODDS (%) | 1 day ago70% | 1 day ago90% |
TrendWeek ODDS (%) | 1 day ago77% | 1 day ago89% |
TrendMonth ODDS (%) | 1 day ago75% | 1 day ago89% |
Advances ODDS (%) | 8 days ago72% | 18 days ago77% |
Declines ODDS (%) | 10 days ago81% | 4 days ago87% |
BollingerBands ODDS (%) | 1 day ago86% | 1 day ago83% |
Aroon ODDS (%) | 1 day ago85% | 1 day ago89% |
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.
Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
---|---|---|---|---|
INGN | 100% | +0.38% | ||
VCYT - INGN | 46% Loosely correlated | +4.68% | ||
CERS - INGN | 40% Loosely correlated | N/A | ||
OSUR - INGN | 39% Loosely correlated | -1.50% | ||
ENOV - INGN | 37% Loosely correlated | -1.39% | ||
OFIX - INGN | 36% Loosely correlated | -0.67% | ||
More |
A.I.dvisor tells us that ZTEK and TLTFF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTEK and TLTFF's prices will move in lockstep.
Ticker / NAME | Correlation To ZTEK | 1D Price Change % | ||
---|---|---|---|---|
ZTEK | 100% | -1.73% | ||
TLTFF - ZTEK | 27% Poorly correlated | +4.10% | ||
VERO - ZTEK | 25% Poorly correlated | +1.10% | ||
RVTY - ZTEK | 25% Poorly correlated | +0.72% | ||
NVNO - ZTEK | 25% Poorly correlated | -3.75% | ||
INGN - ZTEK | 23% Poorly correlated | +0.38% | ||
More |